These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 21175734)

  • 21. The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease.
    Lad SP; Patil CG; Laws ER; Katznelson L
    Neurosurg Focus; 2007; 23(3):E2. PubMed ID: 17961020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cross-sectional study to investigate long-term cognitive function in people with treated pituitary Cushing's disease.
    Heald A; Parr C; Gibson C; O'driscoll K; Fowler H
    Exp Clin Endocrinol Diabetes; 2006 Oct; 114(9):490-7. PubMed ID: 17115346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FSH-producing macroadenoma associated in a patient with Cushing's disease.
    Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
    Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. P53 gene mutation in an atypical corticotroph adenoma with Cushing's disease.
    Kawashima ST; Usui T; Sano T; Iogawa H; Hagiwara H; Tamanaha T; Tagami T; Naruse M; Hojo M; Takahashi JA; Shimatsu A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):656-7. PubMed ID: 18771563
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery.
    Aghi MK; Petit J; Chapman P; Loeffler J; Klibanski A; Biller BM; Swearingen B
    Clin Neurosurg; 2008; 55():141-4. PubMed ID: 19248680
    [No Abstract]   [Full Text] [Related]  

  • 26. Preserved GLP-1 effects in a diabetic patient with Cushing's disease.
    Ritzel RA; Kleine N; Holst JJ; Willms B; Schmiegel W; Nauck MA
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):146-50. PubMed ID: 17318778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [ACTH-dependent Cushing's syndrome: a revision of 43 cases].
    Paiva I; Ribeiro C; Gomes L; Baptista C; Gomes F; Rito M; Rebelo O; Marnoto D; Moura C; Leitão F; Carvalheiro M
    Acta Med Port; 2004; 17(5):367-74. PubMed ID: 16197843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Descriptive Epidemiology and Survival Analysis of Prolactinomas and Cushing's Disease in Korea.
    Park JS; Yun SJ; Lee JK; Park SY; Chin SO
    Endocrinol Metab (Seoul); 2021 Jun; 36(3):688-696. PubMed ID: 34218648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of recurrent Cushing's disease.
    Liubinas SV; Porto LD; Kaye AH
    J Clin Neurosci; 2011 Jan; 18(1):7-12. PubMed ID: 20851608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cushing's disease, hypertension, and other sequels.
    Singer E; Strohm S; Göbel U; Bieringer M; Schmidt D; Schneider W; Kettritz R; Luft FC
    Hypertension; 2008 Dec; 52(6):1001-5. PubMed ID: 18981320
    [No Abstract]   [Full Text] [Related]  

  • 31. Pasireoride (Signifor) for Cushing's disease.
    Med Lett Drugs Ther; 2013 May; 55(1416):39-40. PubMed ID: 23669783
    [No Abstract]   [Full Text] [Related]  

  • 32. Polycythemia as the first manifestation of Cushing's disease.
    Dusek T; Kastelan D; Solak M; Basic Kinda S; Aganovic I; Korsic M
    J Endocrinol Invest; 2008 Oct; 31(10):940. PubMed ID: 19092303
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction: Cushing's disease: a century of evolving diagnostics and therapeutics for an often elusive entity.
    Zada G; Carmichael JD; Selman WR
    Neurosurg Focus; 2015 Feb; 38(2):E1. PubMed ID: 25639311
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19 in Cushing disease: experience of a single tertiary centre in Lombardy.
    Serban AL; Ferrante E; Carosi G; Indirli R; Arosio M; Mantovani G
    J Endocrinol Invest; 2021 Jun; 44(6):1335-1336. PubMed ID: 32915404
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary.
    Bertholf RL
    Clin Chem; 2014 Aug; 60(8):1051. PubMed ID: 25070975
    [No Abstract]   [Full Text] [Related]  

  • 36. [Major increase in the incidence of cirrhosis in Iceland].
    Olafsson S
    Laeknabladid; 2023 Nov; 109(11):491. PubMed ID: 37909443
    [No Abstract]   [Full Text] [Related]  

  • 37. Predictive factors for recurrence of Cushing's disease after pituitary surgery.
    Yazidi M; Oueslati I; Khessairi N; Chaker F; Chihaoui M
    Tunis Med; 2022 Decembre; 100(12):843-846. PubMed ID: 37551534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misdiagnosed psychiatric manifestations in a rare disease: a case report of secondary anxiety syndrome in Cushing's disease.
    Geng W; Cui L; Li T; Liu X; Yao Y; Hong X; Zhu H; Lu L; Wei J
    Front Psychiatry; 2023; 14():1190899. PubMed ID: 37181909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pasireotide treatment in Cushing's disease: A single tertiary center's experience.
    Şahin S; Karimova G; Özcan ŞG; Durcan E; Özkaya HM; Kadıoğlu P
    Turk J Med Sci; 2022 Apr; 52(2):467-476. PubMed ID: 36161631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality.
    Limumpornpetch P; Morgan AW; Tiganescu A; Baxter PD; Nyawira Nyaga V; Pujades-Rodriguez M; Stewart PM
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2377-2388. PubMed ID: 35486378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.